Nektar Therapeutics

+0.24 (+1.09%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)4.09B
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$18.37 Million
Adjusted EPS-$0.74
See more estimates
10-Day MA$22.92
50-Day MA$19.51
200-Day MA$19.82
See more pivots

Nektar Therapeutics Stock, NASDAQ:NKTR

455 Mission Bay Boulevard South, San Francisco, California 94158
United States of America
Phone: +1.415.482.5300
Number of Employees: 723


Nektar Therapeutics is a biopharmaceutical company, which engages in applying technology platforms to develop novel drug candidates. The firm focuses on the therapies for cancer, autoimmune disease, and chronic pain. It operates through the United States and Europe geographical segments. The company was founded in 1990 and is headquartered in San Francisco, CA.